Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junfei Zhao

Showing results (91-100 of 112) with videos related to

Pageof 12
Sort By:
Nature Genetics|February 9, 2021
Comprehensive characterization of protein-protein interactions perturbed by disease mutationsFeixiong Cheng, Junfei Zhao, Yang Wang, et al.
Blood Neoplasia|February 2, 2026
Mezigdomide combined with bortezomib disrupts the cell cycle and elicits superior antitumor effects in multiple myelomaChad C Bjorklund, Marta Larrayoz, Jian Kang, et al.
Nature Communications|June 25, 2026
Glioma-intrinsic MAPK/ERK signaling promotes immunotherapy efficacy through T cell infiltration and interferon responsesKwang-Soo Kim, Junyi Zhang, Víctor A Arrieta, et al.
Neuro-Oncology|August 8, 2018
Distinct genomic profile and specific targeted drug responses in adult cerebellar glioblastomaHee Jin Cho, Junfei Zhao, Sang Won Jung, et al.
Research Square|January 30, 2023
B-cells Drive Response to PD-1 Blockade in Glioblastoma Upon Neutralization of TGFβ-mediated ImmunosuppressionDavid Hou, Brandyn Castro, Mark Dapash, et al.
Blood|May 8, 2026
Ikaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapiesLucia Y Chen, Adolfo Aleman, Marta Larrayoz, et al.
Nature Medicine|February 12, 2019
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastomaJunfei Zhao, Andrew X Chen, Robyn D Gartrell, et al.
Nature Cancer|June 4, 2021
A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistanceJuan M Arriaga, Sukanya Panja, Mohammed Alshalalfa, et al.
Nature Medicine|April 19, 2019
Author Correction: Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastomaJunfei Zhao, Andrew X Chen, Robyn D Gartrell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2021
TOP2B Enzymatic Activity on Promoters and Introns Modulates Multiple Oncogenes in Human GliomasEdgar Gonzalez-Buendia, Junfei Zhao, Lu Wang, et al.
Pageof 12

Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
Nature Genetics|February 9, 2021
Comprehensive characterization of protein-protein interactions perturbed by disease mutationsFeixiong Cheng, Junfei Zhao, Yang Wang, et al.
Blood Neoplasia|February 2, 2026
Mezigdomide combined with bortezomib disrupts the cell cycle and elicits superior antitumor effects in multiple myelomaChad C Bjorklund, Marta Larrayoz, Jian Kang, et al.
Nature Communications|June 25, 2026
Glioma-intrinsic MAPK/ERK signaling promotes immunotherapy efficacy through T cell infiltration and interferon responsesKwang-Soo Kim, Junyi Zhang, Víctor A Arrieta, et al.
Neuro-Oncology|August 8, 2018
Distinct genomic profile and specific targeted drug responses in adult cerebellar glioblastomaHee Jin Cho, Junfei Zhao, Sang Won Jung, et al.
Research Square|January 30, 2023
B-cells Drive Response to PD-1 Blockade in Glioblastoma Upon Neutralization of TGFβ-mediated ImmunosuppressionDavid Hou, Brandyn Castro, Mark Dapash, et al.
Blood|May 8, 2026
Ikaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapiesLucia Y Chen, Adolfo Aleman, Marta Larrayoz, et al.
Nature Medicine|February 12, 2019
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastomaJunfei Zhao, Andrew X Chen, Robyn D Gartrell, et al.
Nature Cancer|June 4, 2021
A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistanceJuan M Arriaga, Sukanya Panja, Mohammed Alshalalfa, et al.
Nature Medicine|April 19, 2019
Author Correction: Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastomaJunfei Zhao, Andrew X Chen, Robyn D Gartrell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2021
TOP2B Enzymatic Activity on Promoters and Introns Modulates Multiple Oncogenes in Human GliomasEdgar Gonzalez-Buendia, Junfei Zhao, Lu Wang, et al.
Pageof 12